Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug
Applied Therapeutics' application for a treatment of a rare metabolic disease was rejected by the Food and Drug Administration. The FDA said the drug, govorestat for galactosemia, had "defici...